EHang Responds to Short Seller Report
November 07, 2023 12:19 ET
|
EHang Holdings Limited
GUANGZHOU, China, Nov. 07, 2023 (GLOBE NEWSWIRE) -- EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world's leading urban air mobility ("UAM") technology platform company,...
EHang Continues to Promote Operations and Commercial Deployment of EH216-S Passenger-Carrying Unmanned Aerial Vehicle System
October 30, 2023 08:06 ET
|
EHang Holdings Limited
GUANGZHOU, China, Oct. 30, 2023 (GLOBE NEWSWIRE) -- EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading urban air mobility (“UAM”) technology platform company,...
Nature Communications publication reveals highly efficient AAV delivery of large genes using ViGeneron’s REVeRT technology
October 25, 2023 08:00 ET
|
ViGeneron GmbH
REVeRT, a dual vector approach based on mRNA trans-splicing, enables delivery of genes larger than the usual AAV packaging size in various tissuesPotential to address prevalent inherited diseases...
uniQure Announces Major Presence at the European Society of Gene and Cell Therapy (ESGCT) Annual Meeting
October 24, 2023 07:05 ET
|
uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, Oct. 24, 2023 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical...
Hefei Municipal Government and EHang Announce Strategic Partnership in Low-Altitude Economy with US$100 Million Support Plan
October 18, 2023 09:29 ET
|
EHang Holdings Limited
GUANGZHOU, China, Oct. 18, 2023 (GLOBE NEWSWIRE) -- EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading urban air mobility (“UAM”) technology platform company,...
EHang Successfully Obtains Type Certificate for EH216-S Passenger-Carrying UAV System Issued by Civil Aviation Administration of China
October 13, 2023 04:57 ET
|
EHang Holdings Limited
GUANGZHOU, China, Oct. 13, 2023 (GLOBE NEWSWIRE) -- EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading urban air mobility (“UAM”) technology platform company,...
Coave Therapeutics appoints Leading World Experts to newly formed Scientific Advisory Board dedicated to its Genetic Medicine Delivery Platform
October 12, 2023 07:00 ET
|
Coave Therapeutics
Paris, France, October 12th, 2023– Coave Therapeutics (‘Coave’), a genetic medicine company focused on developing life-changing therapies, announces the formation of its new Scientific Advisory Board...
Nasdaq Approves EHang’s Request to Suspend Trading of ADSs until no later than October 13, 2023 Pending Material Announcement
October 09, 2023 09:15 ET
|
EHang Holdings Limited
GUANGZHOU, China, Oct. 09, 2023 (GLOBE NEWSWIRE) -- EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading autonomous aerial vehicle (“AAV”) technology platform company,...
[Latest] Global Hemophilia B Gene Therapy Market Size/Share Worth USD 5,938.5 Billion by 2032 at a 34.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
September 27, 2023 16:00 ET
|
Custom Market Insights
Austin, TX, USA, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Hemophilia B Gene Therapy Market Size, Trends and Insights By Treatment Type...
EHang Strategically Invests in Solid-State Lithium Metal Battery Tech Company Inx to Develop Solid-State Battery Supply Chain for eVTOLs
September 20, 2023 07:26 ET
|
EHang Holdings Limited
GUANGZHOU, China, Sept. 20, 2023 (GLOBE NEWSWIRE) -- EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading autonomous aerial vehicle (“AAV”) technology platform...